Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma.

Battistello E, Katanayeva N, Dheilly E, Tavernari D, Donaldson MC, Bonsignore L, Thome M, Christie AL, Murakami MA, Michielin O, Ciriello G, Zoete V, Oricchio E.

Blood. 2018 May 24;131(21):2345-2356. doi: 10.1182/blood-2017-10-809210. Epub 2018 Mar 22.

2.

AR Expression in Breast Cancer CTCs Associates with Bone Metastases.

Aceto N, Bardia A, Wittner BS, Donaldson MC, O'Keefe R, Engstrom A, Bersani F, Zheng Y, Comaills V, Niederhoffer K, Zhu H, Mackenzie O, Shioda T, Sgroi D, Kapur R, Ting DT, Moy B, Ramaswamy S, Toner M, Haber DA, Maheswaran S.

Mol Cancer Res. 2018 Apr;16(4):720-727. doi: 10.1158/1541-7786.MCR-17-0480. Epub 2018 Feb 16.

PMID:
29453314
3.

Sestrin1, a tumor suppressor that can be rescued.

Donaldson MC, Katanayeva N, Oricchio E.

Mol Cell Oncol. 2017 Sep 21;4(6):e1365107. doi: 10.1080/23723556.2017.1365107. eCollection 2017.

PMID:
29209652
4.

Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma.

Oricchio E, Katanayeva N, Donaldson MC, Sungalee S, Pasion JP, B├ęguelin W, Battistello E, Sanghvi VR, Jiang M, Jiang Y, Teater M, Parmigiani A, Budanov AV, Chan FC, Shah SP, Kridel R, Melnick AM, Ciriello G, Wendel HG.

Sci Transl Med. 2017 Jun 28;9(396). pii: eaak9969. doi: 10.1126/scitranslmed.aak9969.

5.

A microfluidic device for label-free, physical capture of circulating tumor cell clusters.

Sarioglu AF, Aceto N, Kojic N, Donaldson MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan TK, Miyamoto DT, Luo X, Bardia A, Wittner BS, Ramaswamy S, Shioda T, Ting DT, Stott SL, Kapur R, Maheswaran S, Haber DA, Toner M.

Nat Methods. 2015 Jul;12(7):685-91. doi: 10.1038/nmeth.3404. Epub 2015 May 18.

6.

Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur R, Stott SL, Shioda T, Ramaswamy S, Ting DT, Lin CP, Toner M, Haber DA, Maheswaran S.

Cell. 2014 Aug 28;158(5):1110-1122. doi: 10.1016/j.cell.2014.07.013.

7.

Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.

Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, Desai R, Zhu H, Comaills V, Zheng Z, Wittner BS, Stojanov P, Brachtel E, Sgroi D, Kapur R, Shioda T, Ting DT, Ramaswamy S, Getz G, Iafrate AJ, Benes C, Toner M, Maheswaran S, Haber DA.

Science. 2014 Jul 11;345(6193):216-20. doi: 10.1126/science.1253533.

8.

Popliteal venous aneurysms: characteristics, management strategies, and clinical outcomes--a modern single-center series.

Donaldson CW, Oklu R, Watkins MT, Donaldson MC, Abtahian F, Schainfeld RM, Jaff MR, Weinberg I.

Ann Vasc Surg. 2014 Nov;28(8):1816-22. doi: 10.1016/j.avsg.2014.06.065. Epub 2014 Jul 7.

PMID:
25011086
9.

Invited commentary.

Donaldson MC.

J Vasc Surg. 2013 Aug;58(2):395. doi: 10.1016/j.jvs.2013.02.004. No abstract available.

10.

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.

Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, Ramaswamy S, Toner M, Haber DA, Maheswaran S.

Science. 2013 Feb 1;339(6119):580-4. doi: 10.1126/science.1228522.

11.

Invited commentary.

Donaldson MC.

J Vasc Surg. 2013 Feb;57(2):361. doi: 10.1016/j.jvs.2012.09.004. No abstract available.

12.

Multiple segmental uniparental disomy associated with abnormal DNA methylation of imprinted Loci in silver-russell syndrome.

Dias RP, Bogdarina I, Cazier JB, Buchanan C, Donaldson MC, Johnston LB, Hokken-Koelega AC, Clark AJ.

J Clin Endocrinol Metab. 2012 Nov;97(11):E2188-93. doi: 10.1210/jc.2012-1980. Epub 2012 Aug 31.

PMID:
22942387
13.

The evolution of functionally referential meaning in a structured world.

Donaldson MC, Lachmann M, Bergstrom CT.

J Theor Biol. 2007 May 21;246(2):225-33. Epub 2007 Jan 9.

PMID:
17280687
14.

Presidential Address. The care of the patient with vascular disease.

Donaldson MC; New England Society for Vascular Surgery.

J Vasc Surg. 2007 Feb;45(2):427-32. No abstract available.

15.

Volunteers: the value of pet therapy.

Donaldson MC.

Caring. 2002 Feb;21(2):14-7.

PMID:
15628285
16.

Infrainguinal vein bypass graft revision: factors affecting long-term outcome.

Nguyen LL, Conte MS, Menard MT, Gravereaux EC, Chew DK, Donaldson MC, Whittemore AD, Belkin M.

J Vasc Surg. 2004 Nov;40(5):916-23.

17.

Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts.

Abbruzzese TA, Havens J, Belkin M, Donaldson MC, Whittemore AD, Liao JK, Conte MS.

J Vasc Surg. 2004 Jun;39(6):1178-85.

18.

Thoracovisceral segment aneurysm repair after previous infrarenal abdominal aortic aneurysm surgery.

Menard MT, Nguyen LL, Chan RK, Conte MS, Fahy L, Chew DK, Donaldson MC, Mannick JA, Whittemore AD, Belkin M.

J Vasc Surg. 2004 Jun;39(6):1163-70.

19.

Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling.

Jacot JG, Abdullah I, Belkin M, Gerhard-Herman M, Gaccione P, Polak JF, Donaldson MC, Whittemore AD, Conte MS.

J Vasc Surg. 2004 Mar;39(3):547-55.

PMID:
14981447
20.

Management of early groin vascular bypass graft infections with sartorius and rectus femoris flaps.

Colwell AS, Donaldson MC, Belkin M, Orgill DP.

Ann Plast Surg. 2004 Jan;52(1):49-53.

PMID:
14676699
21.

Cost-effectiveness targets for multi-detector row CT angiography in the work-up of patients with intermittent claudication.

Visser K, Kock MC, Kuntz KM, Donaldson MC, Gazelle GS, Hunink MG.

Radiology. 2003 Jun;227(3):647-56.

PMID:
12773672
22.

The impact of patient age and aortic size on the results of aortobifemoral bypass grafting.

Reed AB, Conte MS, Donaldson MC, Mannick JA, Whittemore AD, Belkin M.

J Vasc Surg. 2003 Jun;37(6):1219-25.

23.

Preoperative risk factors for carotid endarterectomy: defining the patient at high risk.

Reed AB, Gaccione P, Belkin M, Donaldson MC, Mannick JA, Whittemore AD, Conte MS.

J Vasc Surg. 2003 Jun;37(6):1191-9.

24.

Outcome in patients at high risk after open surgical repair of abdominal aortic aneurysm.

Menard MT, Chew DK, Chan RK, Conte MS, Donaldson MC, Mannick JA, Whittemore AD, Belkin M.

J Vasc Surg. 2003 Feb;37(2):285-92.

25.

Pretreatment imaging workup for patients with intermittent claudication: a cost-effectiveness analysis.

Visser K, Kuntz KM, Donaldson MC, Gazelle GS, Hunink MG.

J Vasc Interv Radiol. 2003 Jan;14(1):53-62.

PMID:
12525586
26.

Transaortic endarterectomy for primary mesenteric revascularization.

Lau H, Chew DK, Whittemore AD, Belkin M, Conte MS, Donaldson MC.

Vasc Endovascular Surg. 2002 Sep-Oct;36(5):335-41.

PMID:
12244421
27.

Initial experience with minimally invasive in situ bypass procedure with blind valvulotomy.

Gangadharan SP, Reed AB, Chew DK, Conte MS, Belkin M, Whittemore AD, Donaldson MC.

J Vasc Surg. 2002 Jun;35(6):1100-6.

28.

Bypass in the absence of ipsilateral greater saphenous vein: safety and superiority of the contralateral greater saphenous vein.

Chew DK, Owens CD, Belkin M, Donaldson MC, Whittemore AD, Mannick JA, Conte MS.

J Vasc Surg. 2002 Jun;35(6):1085-92.

29.

Usefulness of autogenous bypass grafts originating distal to the groin.

Reed AB, Conte MS, Belkin M, Mannick JA, Whittemore AD, Donaldson MC.

J Vasc Surg. 2002 Jan;35(1):48-54; discussion, 54-5.

30.

Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.

de Vries SO, Visser K, de Vries JA, Wong JB, Donaldson MC, Hunink MG.

Radiology. 2002 Jan;222(1):25-36.

PMID:
11756701
31.

Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury?

Eslami MH, Gangadharan SP, Belkin M, Donaldson MC, Whittemore AD, Conte MS.

J Vasc Surg. 2001 Nov;34(5):923-9.

32.

Arterial reconstruction for lower limb ischemia.

Chew DK, Conte MS, Belkin M, Donaldson MC, Whittemore AD.

Acta Chir Belg. 2001 May-Jun;101(3):106-15. Review.

PMID:
11501385
33.

Spontaneous aortic dissection and rupture in a patient with neurofibromatosis.

Chew DK, Muto PM, Gordon JK, Straceski AJ, Donaldson MC.

J Vasc Surg. 2001 Aug;34(2):364-6. Review.

34.

Infrainguinal bypass grafting in patients with end-stage renal disease: improving outcomes?

Lantis JC 2nd, Conte MS, Belkin M, Whittemore AD, Mannick JA, Donaldson MC.

J Vasc Surg. 2001 Jun;33(6):1171-8.

35.

Impact of increasing comorbidity on infrainguinal reconstruction: a 20-year perspective.

Conte MS, Belkin M, Upchurch GR, Mannick JA, Whittemore AD, Donaldson MC.

Ann Surg. 2001 Mar;233(3):445-52.

36.

Autogenous composite vein bypass graft for infrainguinal arterial reconstruction.

Chew DK, Conte MS, Donaldson MC, Whittemore AD, Mannick JA, Belkin M.

J Vasc Surg. 2001 Feb;33(2):259-64; discussion 264-5.

37.

Chronic Venous Insufficiency.

Donaldson MC.

Curr Treat Options Cardiovasc Med. 2000 Jun;2(3):265-272.

PMID:
11096532
38.

Infrainguinal arterial reconstructions with vein grafts in patients with prior aortic procedures: the influence of aneurysm and occlusive disease.

Upchurch GR Jr, Conte MS, Gerhard-Herman MD, Lanoue MZ, Donaldson MC, Mannick JA, Whittemore AD, Belkin M.

J Vasc Surg. 2000 Jun;31(6):1128-34.

39.

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.

Mann MJ, Whittemore AD, Donaldson MC, Belkin M, Conte MS, Polak JF, Orav EJ, Ehsan A, Dell'Acqua G, Dzau VJ.

Lancet. 1999 Oct 30;354(9189):1493-8.

PMID:
10551494
40.

Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.

Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L.

Circulation. 1999 Sep 7;100(10):1043-9.

41.

Improved graft patency and altered remodeling in infrainguinal vein graft reconstruction for aneurysmal versus occlusive disease.

Upchurch GR Jr, Gerhard-Herman MD, Sebastian MW, Belkin M, Conte MS, Donaldson MC, Whittemore AD.

J Vasc Surg. 1999 Jun;29(6):1022-30.

42.

Cost-identification analysis of revascularization procedures on patients with peripheral arterial occlusive disease.

Jansen RM, de Vries SO, Cullen KA, Donaldson MC, Hunink MG.

J Vasc Surg. 1998 Oct;28(4):617-23.

43.

Early operative intervention after thrombolytic therapy for primary subclavian vein thrombosis: an effective treatment approach.

Lee MC, Grassi CJ, Belkin M, Mannick JA, Whittemore AD, Donaldson MC.

J Vasc Surg. 1998 Jun;27(6):1101-7; discussion 1107-8.

44.

Antiplatelet therapy and patency of saphenous-vein bypass grafts in the legs.

Conte MS, Belkin M, Donaldson MC, Whittemore AD.

N Engl J Med. 1998 May 7;338(19):1387-8. No abstract available.

45.

Contralateral symptoms after unilateral intervention for peripheral occlusive disease.

de Vries SO, Donaldson MC, Hunink MG.

J Vasc Surg. 1998 Mar;27(3):414-21.

46.

Health-related quality of life after elective surgery: measurement of longitudinal changes.

Mangione CM, Goldman L, Orav EJ, Marcantonio ER, Pedan A, Ludwig LE, Donaldson MC, Sugarbaker DJ, Poss R, Lee TH.

J Gen Intern Med. 1997 Nov;12(11):686-97.

47.

Stenting for carotid stenosis?

Estes JM, Donaldson MC, Whittemore AD.

N Engl J Med. 1997 Aug 7;337(6):427-8. No abstract available.

PMID:
9244852
48.

Optimal methods for autogenous bypass to the anterior tibial artery.

Eslami MH, Belkin M, Mannick JA, Whittemore AD, Donaldson MC.

Am J Surg. 1997 Aug;174(2):198-201.

PMID:
9293844
49.

Impact of activated protein C resistance on general vascular surgical patients.

Donaldson MC, Belkin M, Whittemore AD, Mannick JA, Longtine JA, Dorfman DM.

J Vasc Surg. 1997 Jun;25(6):1054-60.

50.

Validation of a new and specific intraoperative measurement of vein graft resistance.

Schwartz LB, Belkin M, Donaldson MC, Knox JB, Craig DM, Moawad J, McKinsey JF, Piano G, Bassiouny HS, Whittemore AD.

J Vasc Surg. 1997 Jun;25(6):1033-41; discussion 1041-3.

Supplemental Content

Loading ...
Support Center